Remedy Pharmaceuticals, Inc. — Form D

Remedy Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2012-05-22. The offering totals $2.7M, of which $2.7M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2012-05-22
• Form: D
• Accession: 0001522380-12-000066
• Industry: Pharmaceuticals
• Exemptions: 06
• Total offering: $2.7M
• Amount sold: $2.7M
• Investors: 29
• Date of first sale: 2012-05-09
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-178624

Issuer

• Name: Remedy Pharmaceuticals, Inc.
• CIK: 0001501657
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 122 WEST 27TH STREET, NEW YORK, NY, 10001
• Phone: 212-586-2226

Officers, directors & promoters (5)

Other filings by this issuer (7)

More

• CIK 1501657 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search